Us Bancorp \De\ Amphastar Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 848 shares of AMPH stock, worth $27,314. This represents 0.0% of its overall portfolio holdings.

Number of Shares

848

Previous 7,368 88.49%

Holding current value

$27,314

Previous $357,000 91.32%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$36.84 - $53.4 $240,196 - $348,168	-6,520 Reduced 88.49%	848 $31,000
Q3 2024 Oct 28, 2024	SELL	$36.99 - $50.09 $258,412 - $349,928	-6,986 Reduced 48.67%	7,368 $357,000
Q2 2024 Aug 06, 2024	SELL	$38.65 - $43.48 $104,432 - $117,482	-2,702 Reduced 15.84%	14,354 $574,000
Q1 2024 May 07, 2024	SELL	$42.85 - $63.45 $179,627 - $265,982	-4,192 Reduced 19.73%	17,056 $748,000
Q4 2023 Feb 09, 2024	BUY	$44.49 - $62.93 $910,932 - $1.29 Million	20,475 Added 2648.77%	21,248 $1.31 Million
Q3 2023 Nov 03, 2023	SELL	$45.51 - $65.0 $14,017 - $20,020	-308 Reduced 28.49%	773 $35,000
Q2 2023 Aug 09, 2023	SELL	$35.77 - $58.38 $81,448 - $132,931	-2,277 Reduced 67.81%	1,081 $62,000
Q1 2023 May 09, 2023	BUY	$27.99 - $37.92 $1,623 - $2,199	58 Added 1.76%	3,358 $125,000
Q4 2022 Feb 13, 2023	BUY	$27.93 - $31.27 $22,567 - $25,266	808 Added 32.42%	3,300 $92,000
Q3 2022 Oct 27, 2022	BUY	$27.56 - $37.75 $12,925 - $17,704	469 Added 23.18%	2,492 $70,000
Q2 2022 Aug 01, 2022	BUY	$29.79 - $42.29 $19,959 - $28,334	670 Added 49.52%	2,023 $70,000
Q1 2022 May 11, 2022	BUY	$22.96 - $36.45 $987 - $1,567	43 Added 3.28%	1,353 $49,000
Q4 2021 Feb 11, 2022	BUY	$18.14 - $23.29 $2,702 - $3,470	149 Added 12.83%	1,310 $31,000
Q1 2021 Apr 28, 2021	SELL	$17.21 - $20.65 $533 - $640	-31 Reduced 2.6%	1,161 $21,000
Q3 2020 Nov 10, 2020	SELL	$17.99 - $22.22 $37,814 - $46,706	-2,102 Reduced 63.81%	1,192 $23,000
Q2 2020 Aug 07, 2020	BUY	$14.25 - $22.46 $30,395 - $47,907	2,133 Added 183.72%	3,294 $74,000
Q1 2020 May 13, 2020	SELL	$12.66 - $20.08 $3,000 - $4,758	-237 Reduced 16.95%	1,161 $17,000
Q4 2019 Feb 04, 2020	BUY	$17.07 - $20.64 $23,863 - $28,854	1,398 New	1,398 $27,000
Q2 2019 Aug 13, 2019	SELL	$18.92 - $22.96 $2,648 - $3,214	-140 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$19.46 - $25.28 $2,724 - $3,539	140 New	140 $3,000

Others Institutions Holding AMPH

# of Institutions

279

Shares Held

36.8M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.58B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account